[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344801-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344801-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","machine-learning-predicted-insulin-resistance-is-a-risk-factor-for-12-types-of-cancer","Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer","","Insulin resistance has been proposed as a cancer risk factor, but large-scale epidemiological evidence remains limited. This study applies an AI-derived insulin resistance prediction model using nine clinical parameters to the UK Biobank. The model shows the highest diabetes prediction performance versus BMI and other metabolic markers. It is significantly linked to higher risk of six cancers and shows nominal links to six additional cancers, supporting its use for identifying high-risk individuals and targeted screening.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/machine-learning-predicted-insulin-resistance-is-a-risk-factor-for-12-types-of-cancer/344801/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/machine-learning-predicted-insulin-resistance-is-a-risk-factor-for-12-types-of-cancer/344801.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is AI-IR in this study?","Question",{"text":63,"@type":64},"AI-IR is an artificial intelligence-derived metric predicting insulin resistance using nine clinical parameters. It is applied to estimate insulin resistance status in a non-diabetic setting.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does AI-IR perform compared with BMI and other metabolic markers?",{"text":68,"@type":64},"AI-IR demonstrates the highest predictive performance for diabetes incidence compared with BMI, metabolic syndrome, TG/HDL ratio, and TyG index. It is also a strong predictor for a composite cancer definition compared to BMI and TyG.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancers are significantly associated with higher AI-IR?",{"text":72,"@type":64},"Higher AI-IR is significantly associated with increased risk of uterine, kidney, esophagus, pancreas, colon, and breast cancers. Additional cancers show nominal associations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344801,1791983481,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Article [https://doi.org/10.1038/s41467-026-68355-x](https://doi.org/10.1038/s41467-026-68355-x)  \nMachine learning-predicted insulin resistance is a risk factor for 12 types of cancer  \nReceived: 3 August 2024  \n\n| Accepted: 5 January 2026 |\n| --- |\n| |\n| Check for updates |\n\nChia-Lin Lee 1,2,3,4,5 , Tomohide Yamada 6,7,8, Wei-Ju Liu 1,2, Kazuo Hara7, Toshimasa Yamauchi 8, Shintaro Yanagimoto9 & Yuta Hiraike 9,10,11   \nInsulin resistance is suggested to be a risk factor for cancer; however, largescale epidemiological evidence linking insulin resistance to cancer remains limited. Here we apply a machine learning-based prediction model of insulin resistance with nine clinical parameters, termed artiﬁcial intelligence–derived insulin resistance (AI-IR), to the UK Biobank and demonstrated that AI-IR exhibits the highest predictive performance for diabetes incidence compared to body mass index (BMI), metabolic syndrome (MetS), triglyceride to highdensity lipoprotein cholesterol (TG/HDL) ratio, and triglyceride-glucose (TyG) index. Moreover, AI-IR is signiﬁcantly associated with an increased risk of six cancers (uterine, kidney, esophagus, pancreas, colon, and breast) and showed nominal associations with six additional cancers (renal pelvis, small intestine, stomach, liver and gallbladder, leukemia, and bronchial and lung). When we deﬁne composite cancers by merging cancer types whose risks increase with AI-IR, age-and sex-adjusted hazard ratio is 1.25 (95% conﬁdence interval, 1.20- 1.31; P \u003C1 ×10-11). AI-IR is a better predictor of the composite cancers compared to BMI and TyG index, while its capability is comparable to that of MetS and TG/HDL ratio. We conclude that AI-IR is a robust metric for predicting both diabetes and the composite cancer incidence and could be utilized for identiﬁcation of high-risk individuals and focused screening.  \nInsulin resistance, deﬁned as an impaired response of tissues such as liver, muscle, and adipose tissue to insulin1, is one of the fundamental etiologies of diabetes along with impaired insulin secretion. Indeed, insulin resistance precedes the development of type 2 diabetes1 and also predisposes people to cardiovascular disease2. Insulin resistance is often caused by obesity and its associated  \nchronic inﬂammation, and is accompanied by compensatory hyperinsulinemia.  \nAccumulating evidence indicates that both diabetes3–5 and obesity6–8 are associated with a higher risk of cancer. Therefore, it is reasonable to speculate that insulin resistance, which links diabetes and obesity, is also a risk factor for cancer. In this regard, it has been  \n1Division of Artiﬁcial Intelligence, Department of Digital Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 2Intelligent Data Mining Laboratory, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. 3Division of Endocrinology and Metabolism, Taichung Veterans General Hospital, Taichung, Taiwan. 4School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 5Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan. 6Yamada Diabetes Clinic, Tokyo, Japan. 7Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, Japan. 8Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 9Division for Health Service Promotion, The University of Tokyo, Tokyo, Japan. 10The University of Tokyo Excellent Young Researcher Program, The University of Tokyo, Tokyo, Japan. 11Laboratory for Advanced Research on Pathophysiology of Metabolic  \nDiseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. e-mail: [chialin@vghtc.gov.tw](chialin@vghtc.gov.tw); [hiraike-tky@umin.net](hiraike-tky@umin.net)  \nproposed that insulin resistance and hyperinsulinemia might contribute to cancer growth through the anabolic action of insul","cbCaiiB68fi90R2h","https://ap.wps.com/l/cbCaiiB68fi90R2h","pdf",945757,12,"English","# Background\n## Diabetes, obesity, and cancer risk\n# Methods\n## AI-IR model for insulin resistance prediction\n## Data sources and clinical parameters\n## Comparison with BMI, MetS, TG/HDL, and TyG\n# Results\n## Predictive performance for diabetes incidence\n## Associations with cancer incidence\n## Composite cancer risk analysis\n# Conclusion\n## AI-IR as a robust screening metric","[{\"question\":\"What is AI-IR in this study?\",\"answer\":\"AI-IR is an artificial intelligence-derived metric predicting insulin resistance using nine clinical parameters. It is applied to estimate insulin resistance status in a non-diabetic setting.\"},{\"question\":\"How does AI-IR perform compared with BMI and other metabolic markers?\",\"answer\":\"AI-IR demonstrates the highest predictive performance for diabetes incidence compared with BMI, metabolic syndrome, TG/HDL ratio, and TyG index. It is also a strong predictor for a composite cancer definition compared to BMI and TyG.\"},{\"question\":\"Which cancers are significantly associated with higher AI-IR?\",\"answer\":\"Higher AI-IR is significantly associated with increased risk of uterine, kidney, esophagus, pancreas, colon, and breast cancers. Additional cancers show nominal associations.\"}]","Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer | PDF",1790055307,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56e5607eb9c17353835da68fd93cc58b.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/280e91c83ce10847c40c719dbfc9628f.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bceff023b3d3231b40d389b652c85b46.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9365065c1b8df08b08d79e69ab875c5e.webp",980,1301]